HealthEconomics.Com

Connected. Community.

  • facebook
  • linkedin
  • twitter
  • vimeo
  • rss
  • News
  • Jobs
    • HE Jobs Portal
    • View all Jobs
    • Post a Job
  • Value, Evidence & Access Marketplace
    • About the Marketplace
    • Visit the Marketplace
    • On-demand Webinar
    • Find Out More
  • Industry Events
    • Conferences
    • Webinars
    • HealthEconomics.Com On-demand Webinars
    • Webinar Archives
  • Newsletters
    • Subscribe
    • View All
  • Blog
  • Resources
    • Value Communication
    • Free Marketing Consultation!
    • The Future of Print Medical Journals: How to Stay Relevant
    • Be a Better Writer
    • White Papers
    • Education Resources
    • Syndicated Reports
    • Books
    • Databases
    • Blogs
      • HE-Artists
      • Podcasts
Home » News » Pelosi Seeks Prescription Drug Pricing Legislation Including Medicare Negotiation as House Report Notes Pharma Spent $577 Billion on Stock Buybacks and Dividends

Pelosi Seeks Prescription Drug Pricing Legislation Including Medicare Negotiation as House Report Notes Pharma Spent $577 Billion on Stock Buybacks and Dividends

House Speaker Nancy Pelosi announced she will push for drug pricing legislation to be included in President Biden’s economic budget, claiming that such legislation will not impact innovation. She aims to empower Medicare to directly negotiate prescription drug prices with pharmaceutical companies. She criticized pharma spending on stock buybacks and dividends as a report notes less investment was spent on research and development.

“The report found that 2016 to 2020, the 14 top drug companies spent $577 billion on stock buybacks and dividends, according to the report. That is some $56 billion more than the amount spent on research and development, the report said. It estimates the savings from the drug price bill would equal less than half companies are expected to spend on buybacks and dividends over the next decade.” Read more here.

(Source: Erik Wasson, Bloomberg, 7/8/21)



You might also be interested in:

  • Webinar: Biden, Congress, and Drug Prices 12/10/2021
  • Parexel and Kyoto University Hospital Announce Strategic… 10/28/2021
  • Brii Bio Appoints Coy Stout as Senior Vice President and Head… 10/01/2021
  • NASP Supports Biden Administration’s Rx Drug Cost-cutting… 04/12/2022
  • OM1 Launches Real-World Data Network for Neuroscience and… 03/31/2022
  • Evidence Partners and Clarivate Form Channel Partnership to… 02/01/2022
  • IQVIA Collaborates with HealthCore to Advance Clinical… 09/08/2021

Advertise With Us!View All JobsPost a JobView Current NewsletterSubscribe to Newsletters
Webinar of the Week
Conference of the Week
Link of the Week

HealthEconomics.Com Jobs Portal

  • Senior Manager/Manager, RWE
  • Biostatistician/Statistical Analyst
  • Associate Director, Value & Access Strategy (Remote)
  • Manager, Value and Access Strategy (Remote- US)
  • Manager - Real World Evidence Engagement Lead (Remote- US)
 
Syndicated Reports

Economic & Related Consulting Service Revenues World Report & Database

Healthcare Analytical Testing Services Market worth $9.8 billion by 2026 – Key Players are Eurofins Scientific, SGS S.A., Charles River Laboratories

Risk-Based Monitoring Software Market Worth $511 Million By 2025 – Growing Number Of Clinical Trials To Propel Market Growth

Real-World Evidence Solutions Market – Growth, Trends, COVID-19 Impact, and Forecasts (2021 – 2026)

 
White Papers

The Augmented Rep: A practical field force guide for the Omnichannel era

Rare Disease’s Star Turn

The Next Generation of Information Management

Risk Mitigation for Pharma Manufacturer Programs

HealthEconomics.Com

HealthEconomics.Com

  • News
  • Conferences
  • Reports
  • Jobs
  • Consulting
  • Newsletters
  • White Papers

More Links

  • Jobs
  • Education
  • Graduate Schools
  • Webinar Services

Support & Contact

  • Contact Us

About

  • About Us
  • Advertise
  • Webinar Services
  • HE Institute
  • Testimonials
  • Privacy Policy

Stay Connected

  • facebook
  • twitter
  • linkedin
  • pinterest
  • google-plus
  • youtube
  • rss

HealthEconomics.Com is the world’s most comprehensive and credible CONNECTED COMMUNITYTM that serves as the global link to the health economics & outcomes research (HEOR) and pharma market access stakeholder communities.

HEALTHECONOMICS HZ SMALL V2

HealthEconomics.Com is the world’s most comprehensive and credible CONNECTED COMMUNITYTM that serves as the global link to the health economics & outcomes research (HEOR) and pharma market access stakeholder communities, proving news, education, jobs, resources, policy updates, consulting, advertising, all available via website, newsletters, and social media.

© 2017 Health Economics. All rights reserved.

  • News
  • Jobs
    • HE Jobs Portal
    • View all Jobs
    • Post a Job
  • Value, Evidence & Access Marketplace
    • About the Marketplace
    • Visit the Marketplace
    • On-demand Webinar
    • Find Out More
  • Industry Events
    • Conferences
    • Webinars
    • HealthEconomics.Com On-demand Webinars
    • Webinar Archives
  • Newsletters
    • Subscribe
    • View All
  • Blog
  • Resources
    • Value Communication
    • Free Marketing Consultation!
    • The Future of Print Medical Journals: How to Stay Relevant
    • Be a Better Writer
    • White Papers
    • Education Resources
    • Syndicated Reports
    • Books
    • Databases
    • Blogs
      • HE-Artists
      • Podcasts